Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lazabemide (Ro 19-6327) is a selective and reversible monoamine oxidase B (MAO-B) inhibitor with IC50 values of 0.03 μM for MAO-B and >100 μM for MAO-A.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | $50 | 6-8 weeks | |
25 mg | $108 | 6-8 weeks | |
50 mg | $182 | 6-8 weeks | |
100 mg | $273 | 6-8 weeks | |
1 mL x 10 mM (in DMSO) | $47 | 6-8 weeks |
Description | Lazabemide (Ro 19-6327) is a selective and reversible monoamine oxidase B (MAO-B) inhibitor with IC50 values of 0.03 μM for MAO-B and >100 μM for MAO-A. |
Targets&IC50 | MAO-B:30 nM |
In vitro | LAZABEMIDE is selective, high-affinity ligands for enzymes.?KD and Bmax values for 3H-Ro 41 1049 in rat cerebral cortex were 10.7 nM and 7.38 pmol/mg protein, respectively, and for 3H-Ro 19 6327 were 18.4 nM and 3.45 pmol/mg protein, respectively.?In accordance with their potencies as enzyme inhibitors, binding to MAO-A and MAO-B was competitively inhibited by clorgyline (IC50 = 1.4 nM) and L-deprenyl (selegiline;?IC50 = 8.0 nM), respectively[1]. |
In vivo | Lazabemide is a reversible inhibitor of monoamine oxidase B (MAO-B) with IC50 values of 0.48 and 1.5 μM measured in platelets of human subjects ages 19-36 and 60-78, respectively[2]. |
Alias | Ro 19-6327 |
Molecular Weight | 199.64 |
Formula | C8H10ClN3O |
Cas No. | 103878-84-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 34 mg/mL (170.31 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.